OPTN Projected Dividend Yield
OptiNose Inc ( NASDAQ : OPTN )OptiNose is a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists. Co.'s commercial product, XHANCE® (fluticasone propionate) nasal spray is a therapeutic utilizing its proprietary Exhalation Delivery System™ (EDS®) for the treatment of chronic rhinosinusitis with nasal polyps and. Co.'s solutions also include EDS, which enables the development of drug-device combination products intended for self-administration. Co. has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to provide drug deposition. 20 YEAR PERFORMANCE RESULTS |
OPTN Dividend History Detail OPTN Dividend News OPTN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |